These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 11665976

  • 1. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A, Barr SG, Magder LS, Petri M.
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [Abstract] [Full Text] [Related]

  • 2. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
    Ho A, Magder LS, Barr SG, Petri M.
    Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
    [Abstract] [Full Text] [Related]

  • 3. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic.
    Nasiri S, Karimifar M, Bonakdar ZS, Salesi M.
    Rheumatol Int; 2010 Nov; 30(12):1605-9. PubMed ID: 19809816
    [Abstract] [Full Text] [Related]

  • 4. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.
    Yee CS, Farewell V, Isenberg DA, Rahman A, Teh LS, Griffiths B, Bruce IN, Ahmad Y, Prabu A, Akil M, McHugh N, D'Cruz D, Khamashta MA, Maddison P, Gordon C.
    Arthritis Rheum; 2007 Dec; 56(12):4113-9. PubMed ID: 18050213
    [Abstract] [Full Text] [Related]

  • 5. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups.
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA, Ramsey-Goldman R.
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [Abstract] [Full Text] [Related]

  • 7. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP.
    Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 9. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL, Jones AC, Brown NS, Powell RJ.
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [Abstract] [Full Text] [Related]

  • 10. Determination of serum free light chains as a marker of systemic lupus flare.
    Rodríguez-Cambrón AB, Jiménez-Jiménez J, Blázquez-Cañamero MÁ, Pazos FR, Macía-Villa C, Alcalde-Villar M, Collado-Ramos P, Del Pozo FMC, Álvarez-Andrés E, Cruz-Valenciano A.
    Clin Rheumatol; 2020 Feb; 39(2):449-454. PubMed ID: 31773496
    [Abstract] [Full Text] [Related]

  • 11. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study.
    Zonana-Nacach A, Salas M, Sánchez ML, Camargo-Coronel A, Bravo-Gatica C, Mintz G.
    J Rheumatol; 1995 Jan; 22(1):45-9. PubMed ID: 7699680
    [Abstract] [Full Text] [Related]

  • 12. Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.
    Narayanan K, Marwaha V, Shanmuganandan K, Shankar S.
    Med J Armed Forces India; 2010 Apr; 66(2):102-7. PubMed ID: 27365721
    [Abstract] [Full Text] [Related]

  • 13. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.
    Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH.
    Lupus; 2010 Oct; 19(11):1272-80. PubMed ID: 20605879
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
    Petri M, Singh S, Tesfasyone H, Malik A.
    J Rheumatol; 2009 Nov; 36(11):2476-80. PubMed ID: 19833757
    [Abstract] [Full Text] [Related]

  • 15. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S, Nishiyama S, Aita T, Yoshinaga Y.
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [Abstract] [Full Text] [Related]

  • 16. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J.
    Arthritis Res Ther; 2015 Nov 25; 17():341. PubMed ID: 26608564
    [Abstract] [Full Text] [Related]

  • 17. Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.
    Raymond W, Eilertsen G, Nossent J.
    J Immunol Res; 2018 Nov 25; 2018():8051972. PubMed ID: 30687766
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM.
    Scand J Immunol; 2016 Aug 25; 84(2):95-9. PubMed ID: 27135178
    [Abstract] [Full Text] [Related]

  • 19. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.
    Lupus; 2011 Oct 25; 20(12):1267-74. PubMed ID: 21813587
    [Abstract] [Full Text] [Related]

  • 20. Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus.
    Lim KL, Muir K, Powell RJ.
    Ann Rheum Dis; 1994 Nov 25; 53(11):743-8. PubMed ID: 7826135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.